REGENERX BIOPHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $86.3K, a 1.47% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $511K, a 20.5% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $512K, a 28.7% increase from 2021.
  • Regenerx Biopharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $398K, a 19.8% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $332K, a 23.1% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $511K $86.3K -$1.29K -1.47% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $512K $86.3K -$2.04K -2.31% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-11
Q3 2022 $514K $86.3K -$99.6K -53.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $614K $252K +$190K +307% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $424K $87.6K +$25.9K +41.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $398K $88.4K +$26.6K +43.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-11
Q3 2021 $371K $186K +$112K +151% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $259K $61.7K -$84.7K -57.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $344K $61.7K +$11.9K +23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $332K $61.7K +$11.9K +23.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $320K $74K +$24.1K +48.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $296K $146K +$31.1K +27% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $265K $49.8K -$4.92K -8.98% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $270K $49.8K -$5.89K -10.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $276K $49.8K -$50.2K -50.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $326K $115K +$55.1K +91.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $271K $54.8K -$5.41K -9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $276K $55.7K -$4.45K -7.39% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $281K $100K +$3.15K +3.25% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $277K $60.2K +$12.2K +25.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $265K $60.2K -$6.19K -9.33% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $271K $60.2K +$6.92K +13% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $264K $96.9K +$30.5K +46% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $234K $47.9K -$3.36K -6.55% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $237K $66.4K -$105K -61.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $342K $53.3K +$4.86K +10% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $338K $66.4K +$21.1K +46.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $316K $51.3K -$58.6K -53.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $375K $172K +$143K +510% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $232K $48.4K +$20.8K +75.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 $211K $45.2K +$20K +79.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $191K $110K +$82.8K +306% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-22
Q1 2015 $108K $28.1K -$55.4K -66.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $163K $27.6K +$15.8K +134% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-11
Q3 2014 $148K $25.2K +$3.6K +16.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $144K $27.1K +$7.16K +35.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $137K $83.6K +$63.6K +320% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $73.2K $11.8K -$5.17K -30.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $78.4K $21.6K -$4.97K -18.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $83.4K $19.9K -$47.9K -70.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $131K $19.9K -$37.2K -65.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $168K $17K Oct 1, 2012 Dec 31, 2012 10-K 2014-04-04
Q3 2012 $26.6K -$14.9K -35.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 $67.9K +$29.9K +78.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $57.1K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $41.4K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $38K Mar 31, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.